Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

Published:2016-02-18 Issue:6 Volume:5 Page:e1139275
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Baracco Elisa E.,Pietrocola Federico,Buqué Aitziber,Bloy Norma,Senovilla Laura,Zitvogel Laurence,Vacchelli Erika,Kroemer Guido

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1139275

Reference30 articles.

1. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

2. Immune checkpoints

3. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

4. The anticancer immune response: indispensable for therapeutic success?

5. Immunological aspects of cancer chemotherapy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer;OncoImmunology;2023-03-21

2. Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils;Frontiers in Oncology;2022-05-19

3. MiR-6165 Dysregulation in Breast Cancer and Its Effect on Cell Proliferation and Migration;Iranian South Medical Journal;2021-11-01

4. Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer;Cancer Immunology, Immunotherapy;2021-03-13

5. Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis;2020-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3